UNICREDIT BANK/CALL/AMGEN/400/0.1/17.12.25 | Real-time Bid/Ask 04:14:57 2024-06-26 EDT | ||
| 1.61 EUR / 1.68 EUR | -1.50% |
|
| Current month | +15.97% | ||
| 1 month | +11.33% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-25 | 1.67 | +5.70% |
| 24-06-24 | 1.58 | +19.70% |
| 24-06-21 | 1.32 | -5.71% |
| 24-06-20 | 1.4 | +7.69% |
| 24-06-19 | 1.3 | -0.76% |
Delayed Quote Börse Stuttgart
Last update June 25, 2024 at 02:08 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD1H7J |
| ISIN | DE000HD1H7J1 |
| Date issued | 2023-12-28 |
| Strike | 400 $ |
| Maturity | 2025-12-17 (540 Days) |
| Parity | 10 : 1 |
| Emission price | 1.17 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.09 € |
|---|---|
| Lowest since issue | 0.55 € |
| Delta | 0.31x |
| Omega | 5.649 |
| Premium | 30.85x |
| Gearing | 17.94x |
| Moneyness | 0.7983 |
| Difference Strike | 80.69 $ |
| Difference Strike % | +20.17% |
| Spread | 0.07 € |
| Spread % | 4.12% |
| Theoretical value | 1.665 |
| Implied Volatility | 26.08 % |
| Total Loss Probability | 77.76 % |
| Intrinsic value | 0.000000 |
| Present value | 1.665 |
| Break even | 417.80 € |
| Theta | -0.02x |
| Vega | 0.13x |
| Rho | 0.11x |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
319.3
USD
Average target price
316.4
USD
Spread / Average Target
-0.90%
- Stock Market
- Warrants
- Warrant
